Leveraging immunotherapy in acute myeloid leukemia treatment: Opportunities and challenges

In a clinical review, researchers discuss advances in adoptive cell therapy, bispecific antibodies, immune checkpoint modulation, and cytokine-based therapies for the treatment of acute myeloid leukemia. They discuss current challenges, such as antigen selection, tumor heterogeneity, and microenvironmental immune suppression, as well as potential future approaches.